The Cytochemical Bioassay ofACTH Quantitative cytochemical techniques have recently been applied to the assay of hormones (Alaghband-Zadeh et al. 1974, Daly, Loveridge, Bitensky & Chayen 1974) .
Although assays for several hormones are being developed, most experience so far has been gained with corticotrophin (ACTH). Segments of guinea pig adrenal are maintained in non-proliferative organ culture (Trowell 1959) for 5 hours. This allows them to escape the influence of the guinea pig's own hormonal environment. They are then rapidly chilled to -70°C and sectioned at 20 p,m in a cryostat. Each section is transferred to a microscope slide, and the slide immersed for 1 minute in an incubation medium containing appropriate dilutions of an ACTH standard or of unknown. The incubation medium contains a colloid stabilizer to prevent diffusion of intracellular enzymes from the section into the medium. By means of a suitable slide holder and segmented trough it is possible to react about 50 slides simultaneously. Normally these would include four tenfold dilutions of standard (5 fg/ml-5 pg/ml), and two tenfold dilutions of each unknown (1 in 100 and 1 in 1000 is usual, but 1 in 10 may be used if the level is expected to be very low). The slides are then immersed in a second trough containing a potassium ferricyanide-ferric chloride mixture. Prussian blue (ferric ferrocyanide) is precipitated in the section, proportionally to the concentration of reducing groups present in the tissue. The intensity of stain in the zona reticularis is measured by scanning and integrating microdensitometry. There is an inverse linear correlation between the intensity of staining and the log of the concentration of ACTH. Unknowns may be read from the standard graph, and duplicates should be within ± 15%. Values as low as 500 fg/ml can be determined on 200 ,Abl of unextracted plasma, and even lower values can be assayed with larger plasma volumes. Because the standards and unknowns are assayed on the same animal and the adrenal is isolated in organ culture before being exposed to ACTH, hypophysectomy and rigorous environmental control of the assay animal are not necessary. The method has been applied in physiological and clinical studies ( 
f-melanocyte Stimulating Hormone
It has recently been reported that f-melanocyte stimulating hormone (,-MSH) appears to be absent from the human pituitary. The 22 amino acid peptide, known widely as 'human ,B-MSH' may be an artifactual fragment (probably formed by an enzymic cleavage during certain extraction procedures) of a much larger pituitary peptide, which has been previously identified and termed /-Lipotrophin (fl-LPH) (Scott & Lowry 1974) . /-LPH has 91 amino acids and contains the complete sequence of 'human /-MSH' within the 37-58 portion of the molecule.
The purpose of the present study was to determine whether 'human ,-MSH' was absent, or present, in plasma and in human tumours associated with the inappropriate production of f-MSH-like immunoreactive peptides. These are secreted in association with ACTH in the ectopic ACTH syndrome. Plasmas were fractionated on Biogel P6 and PIO in a saline/albumin buffer and tissues were acid extracted and subjected to gel filtration on a Biogel P6 column eluted with 6 % acetic acid. Fractions were radioimmuno-assayed for ,B-MSH. Human fl-LPH and y-LPH both cross-react completely in this system. In plasmas from 3 patients with Nelson's syndrome, and 1 normal subject following pyrogen administration, no immunoreactivity was found in the expected elution position of 'human f-MSH'. The bulk ofthe immunoreactive material eluted in the position expected for ,B-LPH (Fig 1) . Only a minor portion (<0.5%) of the immunoactivity eluted in fractions beyond the expected elution position of 'human ,3-MSH', but this may be artifactual. In all the plasmas studied, a substantial amount of the ,B-MSH immunoactivity was found in the void volume fractions (M.Wt >20 000). However, we have not yet identified whether this is a possible precursor of /3-LPH, released intact from the pituitary, or
